Tarsons Products Quarterly Results for Trading Insights
TARSONS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹3 Cr
QSept 2025
Tarsons Products Quarterly Results Key Highlights
- Revenue of ₹108 Cr in Sept 2025 (-7.7% vs Mar 2025, +0.0% vs Sept 2024)
- Net Profit of ₹3 Cr in Sept 2025 (-70.0% vs Mar 2025, -70.0% vs Sept 2024)
- EBITDA of ₹33 Cr in Sept 2025 (-19.5% vs Mar 2025)
- Operating Margin of 27.0% in Sept 2025 (-6.0pp vs Mar 2025)
- Earnings Per Share of ₹0.62 in Sept 2025 (-67.7% vs Mar 2025)
Tarsons Products Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 108 | 117 | 95 | 116 | 108 | -7.7% | - |
| Net Profit (₹ Cr) | 3 | 10 | 2 | 5 | 10 | - | - |
| EBITDA (₹ Cr) | 33 | 41 | 28 | 39 | 34 | - | - |
| EPS (₹) | 0.62 | 1.92 | 0.34 | 0.95 | 1.93 | - | - |
| Operating Margin (%) | 27.0% | 33.0% | 27.0% | 28.0% | 26.0% | - | - |
Tarsons Products Share Price Trend Around Quarterly Results
Visualize Tarsons Products's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for Tarsons Products
Additional stock information and data for TARSONS
Revenue Trend (₹ Cr)
Dec 2025
116
Jun 2025
95
Mar 2025
117
Sept 2025
108
Net Profit Trend (₹ Cr)
Dec 2025
5
Jun 2025
2
Mar 2025
10
Sept 2025
3
Operating Margin Trend (%)
Dec 2025
28.0%
Jun 2025
27.0%
Mar 2025
33.0%
Sept 2025
27.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Tarsons Products quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹430,344.72 Cr | 1757.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.2 |
|
Divis Laboratories
Sept 2025 |
₹159,214.78 Cr | 5947.0 | 2,860 | 689 | +7.1% | - | 24.1% | 229.0 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹144,367.29 Cr | 4220.2 | 3,219 | 591 | +11.3% | - | 18.4% | 240.6 |
|
Lupin
Sept 2025 |
₹107,238.09 Cr | 2313.9 | 6,921 | 1,485 | +23.2% | - | 21.5% | 71.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,974.57 Cr | 1254.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores